Results 1 to 2 of 2

Thread: Case : Adrenergic Pharmacology

  1. #1
    Join Date
    Aug 2008
    Posts
    6,603
    Rep Power
    46

    Arrow Case : Adrenergic Pharmacology

    Case : Adrenergic Pharmacology



    Case report:

    A 35 yr. old, overweight female purchased a
    weight-reduction product which contained ephedrine. She is the
    product in accordance with directions on the label for one-month,
    then stopped using it during a vacation week, and then started
    again upon her return to work. Two days after restarting, she was
    awakened by anterior chest pain, which radiated to her left
    shoulder and arm. She experienced numbness in the left arm,
    shortness of breath, and sweating (diaphoresis).



    At the emergency department, she was treated with
    morphine and nitroglycerin. Cardiac catherization revealed 60%
    narrowing of the left anterior descending coronary vessel and a
    50 percent narrowing of the circumflex coronary artery. There was
    no evidence of completely occluded coronary vessels. ECG tracings
    indicated T-wave changes indicative of an acute myocardial
    infarction -- later confirmed by elevated cardiac enzymes.



    Recovery was uneventful; the patient was discharged
    with instructions to avoid using the weight loss product or
    similar weight loss products in the future.


    1.Primary mechanism of ephedrine (orally administered) cardiovascular action:
    A. direct alpha receptor agonist
    B. direct beta-1 receptor agonist
    C. release of stored catecholamines (indirect action)
    D. ephedrine not active following oral administration
    E. release of stored histamine (indirect action)

    2.Properties of ephedrine:
    A. orally active
    B. catecholamine
    C. weak base
    D. A & C
    E. A, B & C

    3.Possible explanations why ephedrine might cause myocardial infarction:
    A. ephedrine may increase myocardial oxygen requirements
    B. promotes coronary vasospasm
    C. both
    D. neither

    4.In this patient, if it were concluded that coronary vasospasm was responsible for acute myocardial infarction, what drugs might reduce the likelihood of a recurrence.
    A. propranolol
    B. metoprolol
    C. diltiazem
    D. ergonovine
    E. all the above

    5.For what reason(s) was/were morphine used in the management of this patient?
    A. pain relief
    B. bradycardic effects
    C. increases cardiac output

    6.What is the major rationale for administration of nitroglycerin to this patient?

    A. decrease myocardial oxygen demand
    B. increase blood pressure
    C. must be administered following morphine

    7.What physiological factors might contraindicate the use of nitroglycerin in a patient with acute myocardial infarction?

    A. low systolic arterial pressure (< 100 mm Hg)
    B. clinical suspicion of right ventricular infarction
    C. both
    D. neither

    8.In this patient, if acute myocardial infarction was caused by ephedrine-induced increased myocardial oxygen demand and if nitroglycerin were unable to reverse this effect, what alternative drug(s) might be effective?

    A. alpha adrenergic blocker
    B. beta-adrenergic blocker
    C. both
    D. neither


    -------------------------------

    Correct Answers

    [HIDE]
    1.Primary mechanism of ephedrine (orally administered) cardiovascular action:
    A. direct alpha receptor agonist
    B. direct beta-1 receptor agonist
    C. release of stored catecholamines (indirect action)
    D. ephedrine not active following oral administration
    E. release of stored histamine (indirect action)

    2.Properties of ephedrine:
    A. orally active
    B. catecholamine
    C. weak base
    D. A & C
    E.X A, B & C

    3.Possible explanations why ephedrine might cause myocardial infarction:

    A. ephedrine may increase myocardial oxygen requirements
    B. promotes coronary vasospasm
    C. both
    D. neither

    4.In this patient, if it were concluded that coronary vasospasm was responsible for acute myocardial infarction, what drugs might reduce the likelihood of a recurrence.
    A. propranolol
    B. metoprolol
    C. diltiazem
    D. ergonovine
    E. all the above

    5.For what reason(s) was/were morphine used in the management of this patient?

    A. pain relief

    B. bradycardic effects
    C. increases cardiac output

    6.What is the major rationale for administration of nitroglycerin to this patient?
    A. decrease myocardial oxygen demand
    B. increase blood pressure
    C. must be administered following morphine

    7.What physiological factors might contraindicate the use of nitroglycerin in a patient with acute myocardial infarction?
    A. low systolic arterial pressure (< 100 mm Hg)
    B. clinical suspicion of right ventricular infarction
    C. both
    D. neither

    8.In this patient, if acute myocardial infarction was caused by ephedrine-induced increased myocardial oxygen demand and if nitroglycerin were unable to reverse this effect, what alternative drug(s) might be effective?
    A. alpha adrenergic blocker
    B. beta-adrenergic blocker
    C. both
    D. neither

    [/HIDE]

    .
    Last edited by trimurtulu; 03-22-2009 at 07:26 PM.

  2. #2
    Join Date
    Aug 2008
    Posts
    6,603
    Rep Power
    46

    Arrow

    Case: Sympathomimetic Drug


    A ten-year old boy was referred to the asthma clinic
    for workup. History: consistent with asthma; on pulmonary
    function testing, a marked reduction of FEV1 was noted.

    1.Autonomic drug: beneficial in treating asthma:
    A. bethanechol (Urecholine)
    B. acetylcholine
    C. ipratropium (Atrovent)
    D. scopolamine
    E. mecamylamine (Inversine)

    2.Drug category most likely to be effective in treating asthma:
    A. beta-1 antagonists
    B. nonselective beta antagonists
    C. beta-2 agonists
    D. muscarinic agonists
    E. none of the above


    --------------------------------
    Answers:

    [HIDE]
    1.Autonomic drug: beneficial in treating asthma:
    A. bethanechol (Urecholine)(would promote bronchoconstriction)
    B. acetylcholine (not appropriate; would promote bronchoconstriction)
    C. ipratropium (Atrovent)
    antimuscarinic; anticholinergic --quaternary atropine derivative; may be effective in blocking parasympathetic-mediated bronchoconstriction

    D. scopolamine (anticholinergic; significant CNS side effects)

    E. mecamylamine (Inversine) (ganglionic blocker -- no role in asthma management)


    2.Drug category most likely to be effective in treating asthma:
    A. beta-1 antagonists
    B. nonselective beta antagonists
    C. beta-2 agonists (effective in promoting bronchodilation; examples:terbutaline, metaproterenol, albuterol)
    D. muscarinic agonists
    E. none of the above
    [/HIDE]

    .
    Last edited by trimurtulu; 03-22-2009 at 07:37 PM.

Thread Information

Users Browsing this Thread

There are currently 1 users browsing this thread. (0 members and 1 guests)

Similar Threads

  1. PHARMACOLOGY CASE STUDY - 10 Cases
    By trimurtulu in forum MCQs
    Replies: 2
    Last Post: 02-28-2010, 07:46 AM

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •